Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Taurine for the Treatment of Canine Dilated Cardiomyopathy

Author(s):  Vail Jane

Issue:  Nov/Dec 2006 - Veterinary Compounding
View All Articles in Issue

Page(s):  421-424

Taurine for the Treatment of Canine Dilated Cardiomyopathy Page 1
Taurine for the Treatment of Canine Dilated Cardiomyopathy Page 2
Taurine for the Treatment of Canine Dilated Cardiomyopathy Page 3
Taurine for the Treatment of Canine Dilated Cardiomyopathy Page 4

Download in electronic PDF format for $75

Abstract:  In dogs, dilated cardiomyopathy is a common cardiac disease that is associated with treatment failure, a progressively compromised quality of life, and eventual death from heart failure. Cardiomyopathy in companion animals is treated with a variety of drugs manufactured for the management of cardiac dysfunction in humans, but often those agents do not produce a significantly beneficial response in veterinary patients. In this article, Laura Ivan, DVM, presents her personal experience with the use of a compounded form of the amino acid taurine in the treatment of her Doberman pinscher, whose dilated cardiomyopathy was characteristically sudden in onset. Robert Borger, RPh, a specialist in veterinary compounding, comments on the preparation of taurine for use in dogs with dilated cardiomyopathy.

Related Keywords: Jane Vail, dogs, dilated cardiomyopathy, heart disorders, cardiac disorders, congestive heart failure, taurine, amino acids, veterinary

Related Categories: NUTRITION AND NUTRICEUTICALS, VETERINARY, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Taurine for the Treatment of Canine Dilated Cardiomyopathy
Vail Jane
Nov/Dec 2006
Pg. 421-424

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

The Treatment of Canine Atopic Disease
Davidson Gigi S
May/Jun 2002
Pg. 210-215

Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Williams LaVonn A
, Riley Kari
Sep/Oct 2009
Pg. 367-371

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
Mar/Apr 2010
Pg. 108-111

Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R
, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2012
Pg. 34-41

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A
, Fokken Dawn
Sep/Oct 2009
Pg. 386-389

Natural Testosterone: Hormone of the Heart
Wright Jonathan V
, Lenard Lane
Mar/Apr 1999
Pg. 88-98

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
Sep/Oct 2008
Pg. 384-390

Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha
, Harger Beau, Estrada Nick
Jul/Aug 2016
Pg. 277-280

Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 1999
Pg. 309-310

Calculations
Prince Shelly J
Sep/Oct 2002
Pg. 387

Compounding for Endocrine Disorders in Adult Patients
Grajeda Betty Jo
, Vail Jane
Jul/Aug 2005
Pg. 275-278

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Attention Deficit Hyperactivity Disorder
Allen Loyd V Jr
Mar/Apr 1997
Pg. 87-89

Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2
Davidson Gigi S
May/Jun 2001
Pg. 214-215

Return to Top